ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)

Date: Sunday, November 7, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

Abstract Number: 0855
Asymptomatic Coronary Artery Disease Assessed by Coronary Computed Tomography in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis
Abstract Number: 0856
Identifying COVID-19 Infection Rates and Outcomes in Patients with Systemic Lupus Erythematosus
Abstract Number: 0857
Association of Telomere Length with Phenotypic Frailty in Systemic Lupus Erythematosus
Abstract Number: 0858
Effect of COVID Infection and COVID Vaccination on SLE Activity, Including Antiphospholipid Antibodies
Abstract Number: 0859
Evaluation of the Montreal Cognitive Assessment as a Screening Tool for Cognitive Dysfunction in Systemic Lupus Erythematosus
Abstract Number: 0860
Associations Between Tricarboxylic Acid Cycle Plasma Metabolites and Fatigue Phenotypes in Black Females with Systemic Lupus Erythematosus: An Untargeted Metabolomics Analysis
Abstract Number: 0861
Systemic Lupus Erythematosus, a Pilot Study of a New Disease Activity Score
Abstract Number: 0862
Prevalence and Risk Factors for Herpes Zoster Reactivation in 1542 Patients with Rheumatic Diseases
Abstract Number: 0863
Serum Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) and Cardiovascular Risk in Systemic Lupus Erythematosus: A Longitudinal Cohort Study
Abstract Number: 0864
Does Obesity Affect Disease Activity Outcomes in Systemic Lupus Erythematosus?
Abstract Number: 0865
Lupus Low Disease Activity State Attainment Provides Significant Protection Against Mortality: A Multi-National, Longitudinal Observational Study
Abstract Number: 0866
Characteristics Associated with Poor COVID-19 Outcomes in People with Systemic Lupus Erythematosus (SLE): Data from the COVID-19 Global Rheumatology Alliance (GRA)
Abstract Number: 0867
A Proteomic/Transcriptomic Analysis Associates with Subclinical Vascular Disease in Systemic Lupus Erythematosus
Abstract Number: 0868
Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity
Abstract Number: 0869
Comparison of Two Frailty Definitions in Women with Systemic Lupus Erythematosus
Abstract Number: 0870
Blood Brain Barrier Integrity and Brain Imaging Patterns in Patients with SLE
Abstract Number: 0871
The Association of Hydroxychloroquine Dosing with Adverse Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Abstract Number: 0872
Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)
Abstract Number: 0873
Clinical and Serological Characteristics of Latin American Patients with Lupus Enteritis: A Case-Control Study
Abstract Number: 0874
Serum Galectin-9 and CXCL-10 but Not Their Urinary Levels Reflect Lupus Activity
Abstract Number: 0875
Renal Function, Adherence and Low Hydroxychloroquine Dosing Predict HCQ Blood Levels and Lupus Disease Activity
Abstract Number: 0876
Antibody Response in Patients with Systemic Lupus Erythematosus After a Two-dose Regimen with SARS-CoV-2 Vaccines (Preliminary Results)
Abstract Number: 0877
Association of HCQ Blood Levels with Type 1 and 2 SLE Activity
Abstract Number: 0878
Investigating the Neutrophil to Lymphocyte Ratio as a Marker of SLE Disease Activity, Health-Related Quality of Life and Depression
Abstract Number: 0879
Anti-dsDNA Antibodies Increase Systemic Lupus Erythematosus Cardiovascular Risk Impairing the Immune and Cardiovascular Systems
Abstract Number: 0880
Health Information Use by SLE Patients Pre and During COVID-19
Abstract Number: 0881
Economic Evaluation of Neuropsychiatric (NP) Lupus in an International Inception Cohort Using a Multistate Model Approach
Abstract Number: 0882
COVID-19 Impact Among Patients with Systemic Lupus Erythematosus
Abstract Number: 0883
Multimorbidity Burden in Systemic Lupus Erythematosus: A Nationwide Study
Abstract Number: 0884
Genetics of Longitudinal Disease Activity in Adults with Systemic Lupus Erythematosus
Abstract Number: 0885
SLE Phenotypes Formed from Machine Learning and Their Associations with Cognitive Impairment
Abstract Number: 0886
Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample
Abstract Number: 0887
Association of Mycophenolate and Azathioprine Use with Cognitive Function in SLE
Abstract Number: 0888
Disease Flares in Lupus Are Concordant with Ruminococcus Blautia Gnavus Blooms Within Unstable Gut Microbiota Communities
Abstract Number: 0889
Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients
Abstract Number: 0890
Depression Is Associated with Frailty in Systemic Lupus Erythematosus Patients: Multicenter Retrospective Analysis Using Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index
Abstract Number: 0891
Quality of Life Assessment in an Indian Inception Cohort (INSPIRE) of SLE Using Lupus QoL Questionnaire
Abstract Number: 0892
Screening for Cognitive Impairment with the Automated Neuropsychological Assessment Metrics in Patients with Systemic Lupus Erythematosus
Abstract Number: 0893
Trajectories of Depressive Symptoms in Systemic Lupus Erythematosus over 7 Years
Abstract Number: 0894
Help-seeking Behaviors and Treatment Preferences for Sleep Problems Among Persons with Lupus
Abstract Number: 0895
Insight into Intraindividual Variability Across Neuropsychological Tests and Its Association with Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus
Abstract Number: 0896
Systemic Lupus Erythematosus Disease Flares After SARS-CoV-2 Vaccination

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences